Drugs effects, behavioral

Aman, M.G. and Pearson, D.A. (1999) Monitoring and measuring drug effects behavioral, emotional, and cognitive effects. In Werry, J.S. and Aman, M.G., eds. Practitioners Guide to Psychoactive Drugs for Children and Adolescents. New York Plenum, pp. 99—164. 

Trulson, M.E. Heym. J. and Jacobs, B.L. Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats. Brain Res 215 275-293, 1981. 

A complete dose-response analysis was generated for PCP for doses from 0.625 to 20 mg/kg IP (data not shown). PCP exhibited dose-related anticonvulsant action when day one minus day three differ ence scores were compared for all doses tested. When retested with saline only on day five, no reduction in convulsant sever it or super-sensitive response was observed (day one minus day five), indicating no carryover drug effect 48 hours after dosing. At behavioral ly equivalent doses, all compounds assayed were clearly anticonvulsant (table 3). TCP was most potent at the doses tested. PCA was the most efficacious, and reduced convulsant severity by 2.58 points. As with PCP, none of the other phencycli-noids had any carryover effects 48 hours after dosing (day one minus day five). 

In 1988, the Surgeon General established three criteria for addiction liability.284 These general areas are Psychoactivity, Compulsive Use (Substance Dependence), and Drug-Reinforced Behavior (Reinforcing Effects). 

Hershkowitz, M. and Szechtman, H., Pretreatment with A1 tetrahydrocannabinol and psychoactive drugs effects on uptake of biogenic amines and on behavior, Eur. J. Pharm., 59, 267, 1979. 

Rothman R., Glowaw J. A review of the effects of dopaminergic agents on human, animals, and drug-seeking behavior, and its implications for medication development. Mol. Neurobiol. 10 1, 1995. 

Palfai T and Jankewicz H (1996). Drugs and Human Behavior. Wm. C. Brown, Madison, WI. Parrott AC (1998). Social drugs Effects upon health. In M Pitts and K Phillips (eds), The Psychology of Health. Routledge, London. 

NEURONAL SUBSTRATES OF HALLUCINOGENIC DRUG EFFECTS ON BEHAVIOR... 

After the client is safe and committed to treatment, other important problems may be addressed effectively. For a client with a drug problem, the next priority is to address problems directly related to drug use behavior. These problems in the third tier may include consequences of drug use in all the domains that have been discussed in this book, or may include behaviors that contribute to drug use. Many of those behaviors that contribute to drug use may be associated with other health or mental health problems. In such instances, a treatment plan will... 

---